Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Breast Journal|September 13, 2003
Paraneoplastic neurologic syndrome associated with occult breast cancer: a case report and review of literatureRamin Altaha, Jame Abraham
Hematology (Amsterdam, Netherlands)|March 9, 2006
Use of rituximab in refractory autoimmune thrombocytopenia following an autologous stem cell transplantSamantha Price, Aaron Cumpston, Ramin Altaha
The West Virginia Medical Journal|February 13, 2004
Breast and ovarian cancer genetics and preventionRamin Altaha, Eddie Reed, Jame Abraham
Journal of Oncology|March 5, 2009
Reinduction of bevacizumab in combination with pegylated liposomal Doxorubicin in a patient with recurrent glioblastoma multiforme who progressed on bevacizumab/irinotecanMohammed Almubarak, Michael Newton, Ramin Altaha
Cancer Investigation|September 30, 2010
Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: report of two cases and review of literatureGovardhanan Nagaiah, Mohammed Almubarak, Mudussara Khan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 14, 2008
A fatal outcome in a patient with glioblastoma multiforme after receiving high-dose methotrexateSamantha Price, William Harless, Somi Rikhye, et al.
Current Pharmaceutical Design|August 13, 2002
Epothilones: a novel class of non-taxane microtubule-stabilizing agentsRamin Altaha, Tito Fojo, Eddie Reed, et al.
International Journal of Molecular Medicine|November 18, 2004
Excision repair cross complementing-group 1: gene expression and platinum resistanceRamin Altaha, Xiaobing Liang, Jing Jie Yu, et al.
The Journal of Supportive Oncology|September 8, 2009
Concordance between substance P levels and antiemetic guidelinesGerald M Higa, Miklos L Auber, Ramin Altaha, et al.
Journal of Neuro-Oncology|September 25, 2008
Comparative analysis of temozolomide (TMZ) versus 1,3-bis (2-chloroethyl)-1 nitrosourea (BCNU) in newly diagnosed glioblastoma multiforme (GBM) patientsMridula Vinjamuri, Rakesh R Adumala, Ramin Altaha, et al.
Pageof 2